Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations. - Perkins DO; Jeffries CD; Clark SR; Upthegrove R; Wannan CMJ; Wray NR; Li QS; Do KQ; Walker E; Paul Amminger G; Anticevic A; Cotter D; et al. (Schizophrenia (Heidelberg, Germany), 2025)